Kamada (KMDA) News Today $5.90 +0.05 (+0.85%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Kamada Ltd. Approves Board Re-Elections and Auditor AppointmentDecember 11, 2024 | markets.businessinsider.comWhat is HC Wainwright's Forecast for Kamada FY2024 Earnings?Kamada Ltd. (NASDAQ:KMDA - Free Report) - Analysts at HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for Kamada in a research note issued to investors on Thursday, November 14th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings ofNovember 18, 2024 | marketbeat.comHC Wainwright Estimates Kamada's Q4 Earnings (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Equities researchers at HC Wainwright cut their Q4 2024 earnings per share estimates for shares of Kamada in a report issued on Thursday, November 14th. HC Wainwright analyst A. Fein now expects that the biotechnology company will earn $0.05 per share forNovember 15, 2024 | marketbeat.comKamada’s Promising Growth Potential Backed by Phase 3 InnovAATe Trial and Strong Market Position Justifies Buy RatingNovember 14, 2024 | markets.businessinsider.comKamada’s Strong Growth and Strategic Expansion in 2024November 14, 2024 | markets.businessinsider.comKamada sees FY24 revenue $158M-$162M, consensus $160.47MNovember 14, 2024 | markets.businessinsider.comKamada Ltd. (NASDAQ:KMDA) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comKamada Ltd. (KMDA) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comFootball: Crystal Palace to investigate racial abuse of KamadaNovember 11, 2024 | msn.comKamada to Release Q3 Financial Results Amid Global ExpansionNovember 8, 2024 | markets.businessinsider.comKamada (KMDA) Scheduled to Post Earnings on WednesdayKamada (NASDAQ:KMDA) will be releasing earnings before the market opens on Wednesday, November 13, Zacks reports.November 7, 2024 | marketbeat.comKamada to Present at the Stifel 2024 Healthcare ConferenceNovember 4, 2024 | markets.businessinsider.comKamada to Present at Stifel Healthcare ConferenceNovember 4, 2024 | markets.businessinsider.comFootball: Kamada winner sends Crystal Palace into League Cup q'finalsNovember 1, 2024 | msn.comAston Villa 1-2 Crystal Palace: Kamada winner as Glasner’s Eagles back on trackOctober 31, 2024 | msn.comKamada's winning goal could kickstart his time at PalaceOctober 31, 2024 | msn.comKamada (NASDAQ:KMDA) Shares Pass Below Two Hundred Day Moving Average - Time to Sell?Kamada (NASDAQ:KMDA) Stock Passes Below 200 Day Moving Average - What's Next?October 24, 2024 | marketbeat.comKamada Ltd. Announces 2024 Annual General MeetingOctober 22, 2024 | markets.businessinsider.comKamada Ltd. (NASDAQ:KMDA) Short Interest UpdateKamada Ltd. (NASDAQ:KMDA - Get Free Report) saw a significant decrease in short interest in September. As of September 30th, there was short interest totalling 16,100 shares, a decrease of 13.9% from the September 15th total of 18,700 shares. Based on an average daily trading volume, of 37,300 shares, the short-interest ratio is presently 0.4 days. Approximately 0.1% of the shares of the stock are sold short.October 16, 2024 | marketbeat.comKamada says Japan can close in on World Cup place against AustraliaOctober 11, 2024 | msn.comKamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving Average - Should You Sell?Kamada (NASDAQ:KMDA) Share Price Crosses Below 200 Day Moving Average - Time to Sell?October 10, 2024 | marketbeat.comHow do Crystal Palace get the most out of the versatile Daichi Kamada?September 25, 2024 | nytimes.comKamada (NASDAQ:KMDA) Stock Passes Below Two Hundred Day Moving Average of $5.45Kamada (NASDAQ:KMDA) Shares Cross Below Two Hundred Day Moving Average of $5.45September 24, 2024 | marketbeat.comKamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in HoustonSeptember 23, 2024 | globenewswire.comY.D. More Investments Ltd Has $3.64 Million Position in Kamada Ltd. (NASDAQ:KMDA)Y.D. More Investments Ltd increased its position in shares of Kamada Ltd. (NASDAQ:KMDA - Free Report) by 1,956.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 726,161 shares of the biotechnology company's stock after bSeptember 12, 2024 | marketbeat.comKamada (NASDAQ:KMDA) Stock Price Crosses Below 200-Day Moving Average of $5.53Kamada (NASDAQ:KMDA) Share Price Passes Below 200 Day Moving Average of $5.53September 4, 2024 | marketbeat.comKamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short SellersAugust 28, 2024 | msn.comKamada (NASDAQ:KMDA) Cut to Buy at StockNews.comStockNews.com downgraded shares of Kamada from a "strong-buy" rating to a "buy" rating in a report on Tuesday.August 27, 2024 | marketbeat.comZacks Small Cap Weighs in on Kamada Ltd.'s Q3 2024 Earnings (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Research analysts at Zacks Small Cap cut their Q3 2024 earnings per share (EPS) estimates for shares of Kamada in a research note issued on Monday, August 19th. Zacks Small Cap analyst D. Bautz now forecasts that the biotechnology company will earn $0.06August 22, 2024 | marketbeat.comKMDA: Revenues Up 13% YoY; Adjusted EBITDA Up 51% YoY…August 20, 2024 | msn.comKamada (NASDAQ:KMDA) Lifted to "Strong-Buy" at StockNews.comStockNews.com raised Kamada from a "buy" rating to a "strong-buy" rating in a research report on Monday.August 19, 2024 | marketbeat.comShort Interest in Kamada Ltd. (NASDAQ:KMDA) Drops By 19.7%Kamada Ltd. (NASDAQ:KMDA - Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 33,800 shares, a decrease of 19.7% from the July 15th total of 42,100 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily trading volume, of 31,100 shares, the short-interest ratio is presently 1.1 days.August 19, 2024 | marketbeat.comKamada Ltd. (NASDAQ:KMDA) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. boosted its stake in Kamada Ltd. (NASDAQ:KMDA - Free Report) by 8.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,325,026 shares of the biotechnology company's stock after buying an additAugust 17, 2024 | marketbeat.comFY2024 EPS Estimates for Kamada Ltd. Lifted by Analyst (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Analysts at HC Wainwright raised their FY2024 earnings per share (EPS) estimates for shares of Kamada in a research note issued on Thursday, August 15th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings per shareAugust 16, 2024 | marketbeat.comBuy Rating Affirmed for Kamada on Strong Clinical and Financial PerformanceAugust 16, 2024 | markets.businessinsider.comKamada (NASDAQ:KMDA) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $11.00 target price on shares of Kamada in a report on Thursday.August 15, 2024 | marketbeat.comQ2 2024 Kamada Ltd Earnings Call TranscriptAugust 15, 2024 | gurufocus.comKamada Ltd (KMDA) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...August 15, 2024 | gurufocus.comKamada Ltd. (KMDA) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comKamada earnings preview: what Wall Street is expectingAugust 13, 2024 | markets.businessinsider.comKamada Q2 2024 Earnings PreviewAugust 13, 2024 | msn.comKamada (KMDA) to Release Quarterly Earnings on WednesdayKamada (NASDAQ:KMDA) will be releasing earnings before the market opens on Wednesday, August 14, Zacks reports.August 8, 2024 | marketbeat.comKamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024August 7, 2024 | globenewswire.comKamada (NASDAQ:KMDA) Stock Passes Below 200-Day Moving Average of $5.57Kamada (NASDAQ:KMDA) Share Price Crosses Below Two Hundred Day Moving Average of $5.57August 6, 2024 | marketbeat.com3 Promising Biotech Stocks You Can Pick Up for Less Than $10July 29, 2024 | investorplace.comKamada Ltd Share Price (KMDA.US)July 23, 2024 | lse.co.ukShort Interest in Kamada Ltd. (NASDAQ:KMDA) Expands By 27.9%Kamada Ltd. (NASDAQ:KMDA - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 43,100 shares, a growth of 27.9% from the May 15th total of 33,700 shares. Currently, 0.1% of the company's shares are short sold. Based on an average trading volume of 18,700 shares, the short-interest ratio is presently 2.3 days.June 17, 2024 | marketbeat.comKamada (NASDAQ:KMDA) Shares Cross Below Two Hundred Day Moving Average of $5.61Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average of $5.61May 31, 2024 | marketbeat.comKMDA: Full Year Guidance Raised; Year-Over-Year Top-Line Growth of 23%…May 23, 2024 | finance.yahoo.com3 Pharma Stocks With May PotentialMay 14, 2024 | stocknews.com Get Kamada News Delivered to You Automatically Sign up to receive the latest news and ratings for KMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now KMDA Media Mentions By Week KMDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KMDA News Sentiment▼0.000.60▲Average Medical News Sentiment KMDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KMDA Articles This Week▼01▲KMDA Articles Average Week Get Kamada News Delivered to You Automatically Sign up to receive the latest news and ratings for KMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Praxis Precision Medicines News Arvinas News Day One Biopharmaceuticals News Ardelyx News Spyre Therapeutics News Calliditas Therapeutics AB (publ) News ARS Pharmaceuticals News ANI Pharmaceuticals News Syndax Pharmaceuticals News Rocket Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KMDA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kamada Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kamada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.